GPR35 as a novel therapeutic target
G protein-coupled receptors (GPCRs) remain the best studied class of cell surface receptors and the most tractable family of proteins for novel small molecule drug discovery. Despite this, a considerable number of GPCRs remain poorly characterised and in a significant number of cases, endogenous lig...
Main Authors: | Amanda eMacKenzie, Jennifer eLappin, Debra eTaylor, Stuart eNicklin, Graeme eMilligan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2011-11-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fendo.2011.00068/full |
Similar Items
-
G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease
by: Nina eDivorty, et al.
Published: (2015-03-01) -
Analysis of the protein related receptor GPR92 in G-cells
by: Amelie Therese Rettenberger, et al.
Published: (2015-09-01) -
The Therapeutic Potential of Orphan GPCRs, GPR35 and GPR55
by: Patricia Hodapp Reggio, et al.
Published: (2015-04-01) -
Drug discovery opportunities at the endothelin B receptor-related orphan G protein-coupled receptors, GPR37 and GPR37L1
by: Nicola J Smith, et al.
Published: (2015-11-01) -
Neuroglobin plays as tumor suppressor by disrupting the stability of GPR35 in colorectal cancer
by: Qin Xiang, et al.
Published: (2023-04-01)